Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation

Long COVID lacks effective pharmaceutical treatment options. Psychedelic treatment for long COVID has received attention given anecdotal reports of neuropsychiatric symptom improvement. This study investigates the use of psilocybin for neuropsychiatric long COVID symptoms, examining online accounts of individuals with reported long COVID using psilocybin. We searched the Reddit communities, "r/LongCovid," and "r/covidlonghaulers" for terms, "psilocybin," "shrooms," and "magic mushrooms." Posts were included if they self-reported (1) neuropsychiatric symptoms of long COVID, (2) use of psilocybin, and (3) descriptions of the perceived effect or lack thereof on long COVID symptoms. Posts were manually coded to identify the nature of psilocybin ingestion, long COVID symptoms, and post's author's perceived effect on symptoms. The most common symptoms identified were fatigue (47.3%, <i>N</i> = 52), cognitive impairment (46.4%, <i>N</i> = 51), and depression (30.0%, <i>N</i> = 33). Of 110 posts meeting criteria, 78.2% (<i>N</i> = 86) reported any improvement in long COVID symptoms, while 11.8% (<i>N</i> = 13) reported worsening. For those with improvement, 77.9% (<i>N</i> = 67) reported improvement lasting beyond their acute psychedelic experience, while 5.8% (<i>N</i> = 5) reported improvement only during the experience. Given these findings, studies employing comparison social media data for other long COVID self-treatments and/or prospective observational studies of individuals self-treating neuropsychiatric long COVID symptoms with psychedelics may be warranted.

Authors

Institutions

Publication Details

Journal
Journal of Psychoactive Drugs
Published
2025-03-14
DOI
https://doi.org/10.1080/02791072.2025.2478097
Citations
2
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
4.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation

Brian S. Barnett, Lukas Bobak, Ian Dorney, Alexsandra Kovacevich
2 citations
Journal of Psychoactive Drugs
Psychedelics and Drug Studies
4.61
article

Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation

Brian S. Barnett, Lukas Bobak, Ian Dorney, Alexsandra Kovacevich
article en
2 citations

Abstract

Long COVID lacks effective pharmaceutical treatment options. Psychedelic treatment for long COVID has received attention given anecdotal reports of neuropsychiatric symptom improvement. This study investigates the use of psilocybin for neuropsychiatric long COVID symptoms, examining online accounts of individuals with reported long COVID using psilocybin. We searched the Reddit communities, "r/LongCovid," and "r/covidlonghaulers" for terms, "psilocybin," "shrooms," and "magic mushrooms." Posts were included if they self-reported (1) neuropsychiatric symptoms of long COVID, (2) use of psilocybin, and (3) descriptions of the perceived effect or lack thereof on long COVID symptoms. Posts were manually coded to identify the nature of psilocybin ingestion, long COVID symptoms, and post's author's perceived effect on symptoms. The most common symptoms identified were fatigue (47.3%, <i>N</i> = 52), cognitive impairment (46.4%, <i>N</i> = 51), and depression (30.0%, <i>N</i> = 33). Of 110 posts meeting criteria, 78.2% (<i>N</i> = 86) reported any improvement in long COVID symptoms, while 11.8% (<i>N</i> = 13) reported worsening. For those with improvement, 77.9% (<i>N</i> = 67) reported improvement lasting beyond their acute psychedelic experience, while 5.8% (<i>N</i> = 5) reported improvement only during the experience. Given these findings, studies employing comparison social media data for other long COVID self-treatments and/or prospective observational studies of individuals self-treating neuropsychiatric long COVID symptoms with psychedelics may be warranted.

Journal of Psychoactive Drugs
Cleveland Clinic (US), Cleveland Clinic Lerner College of Medicine (US), Michigan Medicine (US), Case Western Reserve University (US), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 8%
Psychedelics and Drug Studies
4.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.